The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Besifloxacin hydrochloride

Australian Public Assessment Report

AusPAR

AusPAR: Besifloxacin hydrochloride [PDF, 884.76 KB]

AusPAR: Besifloxacin hydrochloride [Word, 1.7 MB]

Attachment: Product Information: Besifloxacin hydrochloride [PDF, 339.43 KB]

Attachment: Product Information: Besifloxacin hydrochloride [Word, 339.4 KB]

Attachment: Extract from Clinical Evaluation Report: Besifloxacin hydrochloride [PDF, 494.08 KB]

Attachment: Extract from Clinical Evaluation Report: Besifloxacin hydrochloride [Word, 808.18 KB]

Device/Product Name

Besivance

Active ingredients

Besifloxacin hydrochloride

AusPAR Date

3 February 2014

Published

31 March 2014

Submission Number

PM-2012-02740-3-2

Submission Type

New chemical entity

Decision

Approved